Target Name: GALNS
NCBI ID: G2588
Review Report on GALNS Target / Biomarker Content of Review Report on GALNS Target / Biomarker
GALNS
Other Name(s): GalNAc6S sulfatase | chondroitinsulfatase | GALNAC6S | chondroitinase | Chondroitinsulfatase | GALNS_HUMAN | Galactose-6-sulfate sulfatase | GALNS protein (isoform 2) | galactose-6-sulfate sulfatase | Galactosamine (N-acetyl)-6-sulfatase, transcript variant 2 | N-acetylgalactosamine-6-sulfate sulfatase | galNAc6S sulfatase | Galactosamine (N-acetyl)-6-sulfate sulfatase | N-acetylgalactosamine-6-sulfatase | N-acetyl-D-galactosamine-6-sulfate 6-sulfohydrolase | GalN6S | GALNS variant 1 | GAS | GALNS variant 2 | galactosamine (N-acetyl)-6-sulfatase | MPS4A | Chondroitinase | Galactosamine (N-acetyl)-6-sulfatase, transcript variant 1 | galactosamine (N-acetyl)-6-sulfate sulfatase | N-acetylgalactosamine-6-sulfatase (isoform 1)

Understanding GALNS: Enzyme's Role in Disaccharide Breakdown and Glucose Regulation

GALNS (GalNAc6S sulfatase) is a enzyme that is involved in the breakdown of a type of sugar called disaccharide Galactose. Galactose is a key component of the carbohydrate molecules that make up the cell walls of many organisms, including humans. It is found in a variety of foods, including milk, beans, and legumes.

GALNS is a protein that is expressed in many different tissues throughout the body, including the brain, heart, and liver. It is also highly expressed in the placenta, which is the tissue that carries oxygen and nutrients to the developing fetus.

One of the unique features of GALNS is its role in the regulation of the levels of glucose in the body. It is well known that glucose is an important source of energy for the brain, and that it is important to maintain proper levels of glucose in the body to prevent a variety of health problems, including diabetes.

GALNS is involved in the breakdown of Galactose, which is a key component of the carbohydrate molecules that make up the cell walls of many organisms, including humans. It is a critical enzyme in the breakdown of this sugar, and it is essential for the proper functioning of many different tissues and organs in the body.

In addition to its role in the regulation of glucose levels, GALNS is also involved in the production of other important molecules in the body. For example, it is a key enzyme in the production of collagen, a protein that is important for the structure and integrity of many tissues in the body, including blood vessels, bones, and connective tissues.

GALNS is also involved in the regulation of many different signaling pathways in the body. For example, it is well known that GALNS plays a role in the development and progression of cancer. It is also involved in the regulation of cell death, and it is a potential target for the development of new treatments for a variety of diseases.

GALNS is also a potential drug target. Its role in the regulation of glucose and collagen production, as well as its involvement in the regulation of many different signaling pathways, make it a promising target for the development of new treatments for a variety of diseases.

In conclusion, GALNS is a critical enzyme that is involved in the breakdown of a key component of the cell walls of many organisms, as well as the production of other important molecules in the body. Its role in the regulation of glucose and collagen production, as well as its involvement in the regulation of many different signaling pathways, make it a promising target for the development of new treatments for a variety of diseases. Further research is needed to fully understand the role of GALNS in the body and its potential as a drug target.

Protein Name: Galactosamine (N-acetyl)-6-sulfatase

The "GALNS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GALNS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GALNT1 | GALNT10 | GALNT11 | GALNT12 | GALNT13 | GALNT13-AS1 | GALNT14 | GALNT15 | GALNT16 | GALNT17 | GALNT18 | GALNT2 | GALNT3 | GALNT4 | GALNT5 | GALNT6 | GALNT7 | GALNT7-DT | GALNT8 | GALNT9 | GALNT9-AS1 | GALNTL5 | GALNTL6 | GALP | GALR1 | GALR2 | GALR3 | GALT | Gamma Crystallin | Gamma-Aminobutyric acid type B receptor | Gamma-aminobutyric-acid A receptor, Rho | gamma-delta T Cell Receptor (TCR) Complex | Gamma-glutamyl transferase | gamma-Secretase | Gamma-tubulin complex | GAMT | GAN | GANAB | GANC | Gap junction Connexin ( | Gap Junction Protein | GAP43 | GAPDH | GAPDHP1 | GAPDHP14 | GAPDHP21 | GAPDHP38 | GAPDHP42 | GAPDHP56 | GAPDHP62 | GAPDHP65 | GAPDHP72 | GAPDHS | GAPLINC | GAPT | GAPVD1 | GAR1 | GAREM1 | GAREM2 | GARIN1A | GARIN1B | GARIN2 | GARIN3 | GARIN4 | GARIN5A | GARIN5B | GARIN6 | GARNL3 | GARRE1 | GARS1 | GARS1-DT | GART | GAS1 | GAS1RR | GAS2 | GAS2L1 | GAS2L2 | GAS2L3 | GAS5 | GAS6 | GAS6-AS1 | GAS7 | GAS8 | GAS8-AS1 | GASAL1 | GASK1A | GASK1B | GASK1B-AS1 | GAST | GATA1 | GATA2 | GATA2-AS1 | GATA3 | GATA3-AS1 | GATA4 | GATA5 | GATA6 | GATA6-AS1 | GATAD1 | GATAD2A